The U.S. House of Representatives has approved the Food and Drug Administration Reform Act of 2012 (H.R. 5651), including a generic drug user fee program. A Senate version of the bill passed that body...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.